Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -2 of 2 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 11/1/2002 First Published: 7/1/1997


1.		Phase II Pilot Study to Evaluate the Potential Interactions Between Paclitaxel and Protease Inhibitors in Patients With AIDS-Related Kaposi's Sarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				E-1D95 AMC-014, NCT00003008, E1D95

Last Modified: 10/1/2001


2.		Phase I Study to Determine the Safety, Tolerance and Antitumor Effects of a Protease Inhibitor Combined with Interferon Alfa and Two Nucleosides in Patients with HIV Related Kaposi's Sarcoma (Summary Last Modified 10/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				13 and over				NCI				AMC-004 NCI-T96-0076, T96-0076

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute